← All organizations

Principia Biopharma, Inc.

For profitWebsite ↗

Also known as: Principia Biopharma | Principia Biopharma Australia Pty Ltd. | Principia Biopharma Inc. | Principia Biopharma, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 14, 2020

Acquired by Sanofi-Aventis on Aug 17, 2020

Timeline

2000s

Jun 1, 2008
Principia Biopharma, Inc.— Founded

2020s

Aug 17, 2020
Sanofi-Aventis— Acquired By

Drugs by trial phase (2 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

Rilzabrutinib

Phase 1 (1 own, 0 via acquisition)

prn1371

Indications

Studied for

Recent trials (9)

NCT04562766Lead sponsorPhase 3Dec 14, 2020
NCT04562766Study directorPhase 3Dec 14, 2020
NCT03762265Lead sponsorPhase 3Jan 8, 2019
NCT03762265Study directorPhase 3Jan 8, 2019
NCT03395210Study directorPhase 1/Phase 2Dec 5, 2017
NCT03395210Lead sponsorPhase 1/Phase 2Dec 5, 2017
NCT02704429CollaboratorPhase 2Feb 1, 2016
NCT02704429Lead sponsorPhase 2Feb 1, 2016
NCT02608125Lead sponsorPhase 1Nov 1, 2015

Details

Founded: South San Francisco, US Jun 1, 2008
Last known activity: Dec 14, 2020